Protraction of whole blood and plasma clot lysis in patients with high levels of an inhibitor of tissue-type plasminogen activator

Thromb Res. 1985 Aug 1;39(3):271-80. doi: 10.1016/0049-3848(85)90222-1.

Abstract

The influence of the newly discovered, fast-acting inhibitor of tissue-type plasminogen activator (t-PA) on the lysis time of plasma clots was studied by visual observation of lysis of clotted citrated plasma after addition of purified t-PA. To a series of plasma samples with various concentrations of naturally occurring PA-inhibitor purified t-PA was added to a final concentration, which in pooled normal plasma is sufficient to induce clot lysis within a few hours. In those plasma samples with a high free inhibitor level, determined by measuring the recovery of the activity of added purified t-PA, clot lysis was retarded. Whole blood clots were made by clotting freshly collected non-anticoagulated blood with thrombin after admixture of a trace amount of radiolabeled fibrinogen and a fixed amount of t-PA. Lysis rate, read from the appearance of radioactivity in the serum after centrifugation, was significantly lower in clots obtained from subjects with a high free inhibitor level than in those with a low inhibitor level. It is concluded that the PA-inhibitor protracts clot lysis and may be relevant for physiological fibrinolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Coagulation
  • Fibrinolysis*
  • Glycoproteins / blood*
  • Humans
  • In Vitro Techniques
  • Liver Diseases / blood
  • Plasminogen Activators / antagonists & inhibitors*
  • Plasminogen Inactivators*
  • Thromboembolism / blood
  • Time Factors
  • alpha-2-Antiplasmin / physiology

Substances

  • Glycoproteins
  • Plasminogen Inactivators
  • alpha-2-Antiplasmin
  • Plasminogen Activators